Alzheimer's Treatment
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
72
NCT06562114
A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 11, 2024
Completion: Jul 31, 2025
Loading map...